Implantable Cardioverter-Defibrillators Among Older Survivors of Out-of-Hospital Cardiac Arrest

Mason Marcus1, Paul S Chan2, Anping Chang3

  • 1University of Texas-Southwestern Medical Center Dallas TX USA.

Insights

Fewer than one-third of out-of-hospital cardiac arrest survivors with a shockable rhythm received an implantable cardioverter-defibrillator (ICD). ICD use varied significantly across hospitals, independent of patient factors, highlighting a need for improved secondary prevention strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Current guidelines recommend implantable cardioverter-defibrillators (ICDs) for secondary prevention in out-of-hospital cardiac arrest (OHCA) survivors.
  • Contemporary data on ICD utilization in this population remain limited.

Purpose of the Study:

  • To examine contemporary rates of secondary-prevention ICD implantation in OHCA survivors with a shockable rhythm.
  • To identify patient-level factors associated with ICD implantation.
  • To quantify hospital variation in ICD implantation rates.

Main Methods:

  • Analysis of 3226 OHCA survivors (aged ≥65 years) with a shockable rhythm from the 2013-2019 Cardiac Arrest Registry to Enhance Survival (CARES) linked to Medicare.
  • Multivariable hierarchical regression models were used to assess associations between patient variables and ICD implantation and hospital variation.
  • Outcomes included ICD implantation before discharge, at 90 days, and within 6 months.

Main Results:

  • Overall, 30.9% of eligible survivors received an ICD before discharge.
  • Older age, female sex, diabetes, and presentation with acute myocardial infarction were associated with lower odds of ICD implantation.
  • No significant association was found between race/ethnicity and ICD implantation.
  • Significant hospital variation in ICD implantation rates was observed, with a 62% difference in odds after adjusting for case mix.

Conclusions:

  • Less than one-third of OHCA survivors with a shockable rhythm received a secondary-prevention ICD before discharge.
  • Patient factors, but not race or ethnicity, were associated with ICD implantation.
  • Marked variation in ICD implantation exists across hospitals, even after adjusting for patient characteristics.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...